| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 10/04/2007 | WO2007111294A1 Histamine release inhibitor |
| 10/04/2007 | WO2007111227A1 Acylaminopiperidine compound |
| 10/04/2007 | WO2007109882A1 Anti-diabetic cataract compounds and their uses |
| 10/04/2007 | WO2007054822A3 Use of at least one avermectin or milbemycin in the treatment of ophthalmic pathologies |
| 10/04/2007 | WO2007039201A3 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 10/04/2007 | US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof |
| 10/04/2007 | US20070232535 GFRalpha3 and its uses |
| 10/04/2007 | US20070231898 culturing in a mixture of fibroblast growth factor, thyroid hormone, and retinoic acid; differentiated cell population which generate glial cells for treating central nervous system traumas and disorders |
| 10/04/2007 | US20070231405 Compositions and Methods Using Same for Treating Neurodegenerative Disorders |
| 10/04/2007 | US20070231310 Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells |
| 10/04/2007 | US20070231269 Analgesics |
| 10/04/2007 | US20070231267 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 10/04/2007 | CA2645488A1 Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions |
| 10/04/2007 | CA2644488A1 Anti-diabetic cataract compounds and their uses |
| 10/03/2007 | EP1840125A2 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 10/03/2007 | EP1839669A1 Novel angiogensis inhibitor |
| 10/03/2007 | EP1838717A2 Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same |
| 10/03/2007 | EP1838262A1 Linseed eye compresses |
| 10/03/2007 | EP1511722B1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
| 10/03/2007 | EP1355631B1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
| 10/03/2007 | EP1353672B1 Synthesis of 4-amino-thalidomide enantiomers |
| 10/03/2007 | EP1307458B1 Pyrrolotriazolopyrimidinone derivatives |
| 10/03/2007 | EP1306093B1 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient |
| 10/03/2007 | EP1267839B1 Microspheres for active embolization |
| 10/03/2007 | EP1023081B1 Use of recombinant human uteroglobin in treatment of fibrotic conditions |
| 10/03/2007 | CN101048156A Inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| 10/03/2007 | CN101045057A Application of tetramethylpyrazine for preparing medicine to treat neovascular retina diseases |
| 10/03/2007 | CN101045056A Eyedrops for treating glaucoma and its preparing method |
| 10/03/2007 | CN100340573C Heterocarpine, human GHRH-binding protein |
| 10/03/2007 | CN100340556C Novel aryllimidazole derivatives, preparation and therapeutic used thereof |
| 10/03/2007 | CN100340548C Novel arylheteroalkylamine derivatives |
| 10/03/2007 | CN100340241C Eye drop and its preparing method and use |
| 10/02/2007 | US7276518 For therapy of neuropathic or chronic pain |
| 10/02/2007 | US7276509 Substance P; 2-(phenyl)-4-(3-oxo-piperazin-1-yl-)-piperidine-1-carboxylic acid; benzyl-methylamide; antagonists of the NK1 receptor; antidepressant, antiolytic; antiemetic |
| 10/02/2007 | US7276504 Nasally administering an imidazotriazinone substituted with an (alkoxy)(aminosulfonyl)phenyl group for treating diseases including psoriasis, female infertility, diabetes, glaucoma, cystic fibrosis, pre-eclampsia, Parkinsonism, tinnitus, pain, gastric motility disorders, and pulmonary hypertension |
| 10/02/2007 | US7276500 Substituted amides, their preparation and use |
| 10/02/2007 | US7276494 Photodynamic therapy; anticancer agents, vision defects, autoimmune disease, restenosis, skin disorders; cancer vaccine; medical diagnosis |
| 10/02/2007 | US7276364 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 10/02/2007 | CA2412564C Purine derivatives |
| 10/02/2007 | CA2387357C Derivatives of pyrazolo[4,3-d]pyrimidin-7-ones which inhibit cyclic guanosine 3',5'-monophosphate phosphodiesterase |
| 10/02/2007 | CA2378613C Selective iglur5 receptor antagonists for the treatment of migraine |
| 10/02/2007 | CA2298033C Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 09/27/2007 | WO2007108557A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 09/27/2007 | WO2007108541A1 Ophthalmic composition comprising xanthan gum and glucose |
| 09/27/2007 | WO2006124862A3 Methods for the treatment of ocular and neurodegenerative conditions in a mammal |
| 09/27/2007 | US20070225727 Transparent Tissue-Visualizng Preparation |
| 09/27/2007 | US20070225369 Ophthalmic composition for treating tear dysfunction |
| 09/27/2007 | US20070225359 Dimeric compounds and their use as anti-viral agents |
| 09/27/2007 | US20070225321 2,4-pyrimidinediamine compounds and their uses |
| 09/27/2007 | US20070225300 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 09/27/2007 | US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 09/27/2007 | DE102006013594A1 Quervernetzte Gele von Hyaluronsäure und deren Verwendung Cross-linked gels of hyaluronic acid and their use |
| 09/27/2007 | CA2647769A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 09/27/2007 | CA2645867A1 Substituted gamma lactams as prostaglandin ep2 agonists |
| 09/26/2007 | EP1559715B1 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 09/26/2007 | EP1532981B1 Stable eye drops containing latanoprost as the active ingredient |
| 09/26/2007 | EP1451153B1 Nk1 antagonists |
| 09/26/2007 | EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/26/2007 | EP1383750B1 Urea derivatives as integrin alpha 4 antagonists |
| 09/26/2007 | EP1261585B1 Substituted indole mannich bases |
| 09/26/2007 | EP1228046B1 Phthalazinone derivatives as pde 4 inhibitors |
| 09/26/2007 | CN101041626A Tetrafluorobenzyl derivatives and pharmaceutical composition containing same |
| 09/26/2007 | CN101040893A Blueberry capsule for protecting vision and the preparing method |
| 09/26/2007 | CN100339379C 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-1,3-dihydoimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 09/26/2007 | CN100339376C Nitrogen-containing aromatic ring derivatives |
| 09/26/2007 | CN100339374C Compounds and methods for modulation of estrogen receptors |
| 09/26/2007 | CN100339356C Aminoadamantane derivatives as therapeutic agents |
| 09/26/2007 | CN100339130C 疫苗 Vaccine |
| 09/25/2007 | US7273875 Blocking tumor necrosis factor; antiinflammatory agents; respiratory system disorders; bronchodilator |
| 09/25/2007 | US7273857 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | US7273751 Comprises nucleotide sequences associated with expression vector coding endothelial growth factor for use in diagnosis and treatment of tumor angiogenesis, inflammation, diabetic retinopathy, arthritis and psoriasis; wound healing agent |
| 09/25/2007 | US7273744 Heparanase-like polypeptides |
| 09/25/2007 | US7273612 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/25/2007 | CA2484240C Packaged ocular irrigating solution bag |
| 09/20/2007 | WO2007106723A2 Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives |
| 09/20/2007 | WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/20/2007 | WO2007105753A1 Triazole derivative or salt thereof |
| 09/20/2007 | WO2007105691A1 Aqueous composition |
| 09/20/2007 | WO2007105637A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | WO2007104566A1 Substance for the treatment of tinnitus |
| 09/20/2007 | WO2007104541A2 Compositions and methods using serine protease inhibiting peptides for treating ophthalmic disorders |
| 09/20/2007 | US20070219262 omega-Cycloalkyl 17-Heteroaryl Prostaglandin E2 Analogs as EP2-Receptor Agonists |
| 09/20/2007 | US20070219256 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 09/20/2007 | US20070219233 Substituted Indoles and Their Use as Integrin Antagonists |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070219142 Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye |
| 09/20/2007 | DE102006011922A1 Mittel zur Behandlung von Tinnitus Agents for the treatment of tinnitus |
| 09/20/2007 | CA2646528A1 Substance for the treatment of tinnitus |
| 09/20/2007 | CA2646513A1 Antibodies to egfl7 and methods for their use |
| 09/20/2007 | CA2646285A1 Compositions and methods for treating ophthalmic disorders. |
| 09/20/2007 | CA2645712A1 Triazole derivative or salt thereof |
| 09/20/2007 | CA2645311A1 Aqueous composition comprising 15-keto-prostaglandin for ophthalmic use |
| 09/20/2007 | CA2644368A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | CA2643070A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/19/2007 | EP1835023A1 Human corneal endothelial cell-derived precursor cell and cell aggregate, process for producing the same, and method for transplanting precursor cell and cell aggregate |
| 09/19/2007 | EP1834947A2 3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 09/19/2007 | EP1833832A1 Napthyridine compounds as rock inhibitors |
| 09/19/2007 | EP1833491A1 Topical compositions comprising one or more of 44-thiouridine, isomaltitol and uridine |
| 09/19/2007 | EP1833474A1 Pharmaceutical compositions based on fluorinated sulphamides and sulphinimides |